T

Active Director Director DIN 11183539
DIN 11183539 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Tabassum

Data last updated:

Tabassum is a Director at Dosetek India Lifesciences Private Limited (since 2025). The company operates in Healthcare.

DIN 11183539
Primary Designation Director
Industry Healthcare
First Appointment 15 Jul 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20252024Active

Board colleagues of Tabassum

NameDINCompanyDesignation
Pawan Kumar Yadav09799422Dosetek India Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dosetek India Lifesciences Private Limited
Premium access

Shareholding and investment profile for Tabassum

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tabassum

Tabassum currently holds 1 directorship: Dosetek India Lifesciences Private Limited (Director, since 15 Jul 2025).

Tabassum was first appointed on 15 Jul 2025 as Director at Dosetek India Lifesciences Private Limited.

The current boards of Tabassum's companies include Pawan Kumar Yadav (Dosetek India Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available